Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)
Taiwan · Delayed Price · Currency is TWD 34.50
-0.15 (-0.43%)
Aug 19, 2026, 1:30 PM CST
TPE:1762 Market Cap
TPE:1762 has a market cap or net worth of 2.67 billion as of August 19, 2026. Its market cap has increased by 24.42% in one year.
Market Cap
2.67B
Enterprise Value
3.09B
Revenue
934.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.50
ChartMarket Cap Chart
Since December 10, 2009, TPE:1762's market cap has decreased from 5.27B to 2.67B, a decrease of -49.38%. That is a compound annual growth rate of -3.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 2.67B | 41.43% |
| Dec 31, 2025 | 1.88B | -28.33% |
| Dec 31, 2024 | 2.63B | -40.94% |
| Dec 29, 2023 | 4.45B | -12.50% |
| Dec 30, 2022 | 5.09B | 1.08% |
| Dec 30, 2021 | 5.03B | 5.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 3.14B |
| Shine-On BioMedical | 3.13B |
| Apex Biotechnology | 3.08B |
| Great Novel Therapeutics Biotech & Medicals | 3.06B |
| Intech Biopharm | 2.85B |
| 3D Global Biotech | 2.85B |
| BRIM Biotechnology | 2.71B |
| Energenesis Biomedical CO.,LTD. | 2.69B |